HSD74 Cost Savings as a Result of Biosimilar Medications Adoption in One of the Tertiary Governmental Hospitals in Riyadh, Saudi Arabia.
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1625
https://www.valueinhealthjournal.com/article/S1098-3015(23)04755-1/fulltext
Title :
HSD74 Cost Savings as a Result of Biosimilar Medications Adoption in One of the Tertiary Governmental Hospitals in Riyadh, Saudi Arabia.
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04755-1&doi=10.1016/j.jval.2023.09.1625
First page :
Section Title :
Open access? :
No
Section Order :
11069